SGAM
KERX

Smith Group Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Smith Group Asset Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-82,100
Closed -$1.4M – 466
2014
Q1 		$1.4M Buy
+82,100
New +$1.4M 0.05% 171